This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Disinfectant Qualification Questions Are Answered For Sterile Drug Manufacturers In New White Paper

AGAWAM, Mass., March 20, 2013 /PRNewswire/ -- Manufacturers of sterile drug products are required by the FDA to undertake disinfectant qualification studies to determine the effectiveness of their disinfecting agents. A new white paper, " Disinfectant Qualifications: Insight and Perspective, " answers the most frequently asked questions about conducting a successful study. Download the paper from Microtest Laboratories at http://microtestlabs.com/disinfectant-qualifications.

Disinfectant qualification studies provide aseptic manufacturers with detailed information on their use of disinfectants, the level of their effectiveness, and the appropriateness of their use. With variables such as surfaces, disinfectants used, and organisms, it is imperative that disinfectant studies be carried out correctly and thoroughly.

The white paper, in a question and answer format, reviews the methodology involved in a disinfectant qualification study and explains what is to be expected when one is initiated. Answers are provided to such FAQs as:

  • What companies should perform such studies?
  • Why should the studies be undertaken?
  • How are the studies executed?
  • What should be included?
  • How long is the study process?
  • How much does a study cost?

The white paper is authored by three Microtest Laboratory regulatory microbiology and contract laboratory experts with a combined 41 years of experience: Deborah Ensign, Shawn Sherry, and Kate Bloomrose.

With FDA regulations requiring clean rooms to meet prescribed standards, a thorough, well conducted disinfectant study will not only help manufacturers of sterile drug products meet FDA regulations, but also protect product integrity and safety.

Download a copy of the new white paper, " Disinfectant Qualifications: Insight and Perspective, " from the Microtest Laboratories website at http://microtestlabs.com/disinfectant-qualifications. Or, request a copy by calling 1-413-786-1680 or toll-free 1-800-631-1680.

About Microtest LaboratoriesMicrotest Laboratories is a full-service medical device testing laboratory and provider of related services for the medical device, pharmaceutical, and biotechnology industries. Medical device testing is performed in-house by seasoned regulatory microbiologists and chemists under strict GMP/GLP regulations. Microtest is both ISO 9000 and 17025 certified. Testing services include bioburden, sterility, endotoxin, accelerated aging, and toxicity (ISO 10993). In addition, Microtest recently introduced a fast-track test to screen plastics and polymers in medical devices for toxicity using Zebrafish embryos.

Based in Agawam, Massachusetts, USA, the company provides expertise and flexible processes that enhance product safety and security, accelerate time to market, and minimize supply chain disruption. For more information, visit http://www.microtestlabs.com, or call 1-413-786-1680 or toll-free 1-800-631-1680. Follow on Twitter at http://twitter.com/MicrotestLabs.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Steve Richter, Ph.D. | http://www.profnetconnect.com/steve_richter_ph.d

SOURCE Microtest Laboratories

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,985.61 +78.99 0.47%
S&P 500 1,972.83 +9.12 0.46%
NASDAQ 4,419.0340 +27.5710 0.63%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs